IP Verse

Cellular Models Of And Therapies For Ocular Diseases

Patent No. EP3662066 (titled "Cellular Models Of And Therapies For Ocular Diseases") was filed by Reflection Biotechnologies on Jul 31, 2018. The application was issued on Jun 5, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
WEICKMANN & WEICKMANNMar 4, 2025-
DE CLERCQ & PARTNERSFeb 28, 2025DE CLERCQ & PARTNERS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3662066

REFLECTION BIOTECHNOLOGIES
Application Number
EP18842071A
Filing Date
Jul 31, 2018
Status
Granted And Under Opposition
May 3, 2024
Publication Date
Jun 5, 2024
External Links
Slate, Register , Google Patents